|
Renal Cell Cancer
|
|
Renal cell carcinoma
|
Renal Cell Cancer Clinical Trials
- Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00068393 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00060307 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer; stage III renal cell cancer
- ABT-510 in Treating Patients With Locally Recurrent or Metastatic Renal Cell (Kidney) Cancer
ClinicalTrials.gov Identifier: NCT00080704 - Active, not recruiting
recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
- Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003520 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Renal Cell Adenocarcinoma; ...
- Sorafenib and Interferon alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00098618 - Active, not recruiting
recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma; renal granular cell carcinoma
- Vaccine Therapy in Treating Patients With Kidney Cancer
ClinicalTrials.gov Identifier: NCT00096629 - Active, not recruiting
recurrent renal cell cancer; stage I renal cell cancer; stage II renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
- Shark Cartilage Extract in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00005995 - Active, not recruiting
Stage IV Renal Cell Cancer; Renal Cell Adenocarcinoma; recurrent renal cell cancer
- Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00077129 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00089102 - Active, not recruiting
recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
- Chemotherapy in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00024388 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00032188 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
- UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00030888 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126659 - Active, not recruiting
renal clear cell carcinoma; recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically
ClinicalTrials.gov Identifier: NCT00003664 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Quality of Life
- Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00087022 - Recruiting
renal clear cell carcinoma; stage I renal cell cancer; stage II renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
- Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003585 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Vaccine Therapy in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00004880 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- BAY 59-8862 in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00039169 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interferon alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002737 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Renal Cell Adenocarcinoma
- High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
ClinicalTrials.gov Identifier: NCT00080977 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00006864 - Active, not recruiting
Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
- Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer
ClinicalTrials.gov Identifier: NCT00083109 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer
ClinicalTrials.gov Identifier: NCT00004890 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; drug extravasation; recurrent renal cell cancer; stage I renal cell cancer; ...
- Interferon alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00072046 - Active, not recruiting
Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
- Lymphocyte Therapy in Treating Patients With Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002589 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer
ClinicalTrials.gov Identifier: NCT00025519 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; renal clear cell carcinoma
- Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003181 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- PS-341 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00025376 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer
ClinicalTrials.gov Identifier: NCT00058318 - Active, not recruiting
Stage IV Renal Cell Cancer; stage III renal cell cancer
- Tretinoin and Interleukin-2 in Treating Patients With Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00100906 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; renal clear cell carcinoma
- Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00039429 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Oblimersen and Interferon alfa in Treating Patients With Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00059813 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003102 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Volociximab in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00103077 - Recruiting
recurrent renal cell cancer; renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00042965 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003928 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Sorafenib, Gemcitabine, and Capecitabine in Treating Patients with Unresectable and/Or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00121251 - Recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; stage III renal cell cancer
- AZD2171 in Treating Patients With Progressive Locally Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00227760 - Active, not recruiting
Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer
- CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer
ClinicalTrials.gov Identifier: NCT00112840 - Recruiting
recurrent renal cell cancer; renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Magnetic-Resonance-Guided Radiofrequency Ablation in Treating Patients With Primary Kidney Cancer, Liver Metastases, or Other Solid Tumors
ClinicalTrials.gov Identifier: NCT00006255 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer; unspecified adult solid tumor, protocol specific; ...
- Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00085436 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Dolastatin 10 in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003914 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- FR901228 in Treating Patients With Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00060216 - Recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Tretinoin Plus Interferon alfa in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003656 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002846 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003584 - Active, not recruiting
Stage IV Renal Cell Cancer; childhood kidney/urinary cancer; recurrent renal cell cancer
- Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00005038 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00091403 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma
- Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00073879 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Vaccine Therapy in Treating Patients With Kidney Cancer
ClinicalTrials.gov Identifier: NCT00014131 - Recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00093522 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Sorafenib and Bevacizumab in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126503 - Recruiting
renal clear cell carcinoma; recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00016042 - Active, not recruiting
recurrent colon cancer; Stage IV Renal Cell Cancer; Stage IV rectal cancer; recurrent rectal cancer; recurrent renal cell cancer; ...
- Capecitabine Plus GTI-2040 in Treating Patients With Advanced or Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00084331 - Recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00005816 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung
ClinicalTrials.gov Identifier: NCT00006483 - Active, not recruiting
Stage IV Renal Cell Cancer; lung metastases; recurrent renal cell cancer
- Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126490 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer
ClinicalTrials.gov Identifier: NCT00014183 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer
ClinicalTrials.gov Identifier: NCT00039052 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; recurrent non-small cell lung cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer; ...
- SU011248 or Interferon alfa in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00098657 - Recruiting
recurrent renal cell cancer; renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Interferon alfa in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003542 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Study Of Su011248 Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00137423 - Active, not recruiting
Carcinaoma RENAL CELL
- Interferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002847 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery
ClinicalTrials.gov Identifier: NCT00003604 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Interferon alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
ClinicalTrials.gov Identifier: NCT00005966 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00004135 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Stage IV Melanoma; Recurrent Melanoma
- Fludarabine, Total-body Irradiation, Donor Peripheral Stem Cell Transplantation, and Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00005799 - Active, not recruiting
Leukemia; Renal Cell Cancer; Lymphoma; Eye Cancer; Kidney Cancer
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
ClinicalTrials.gov Identifier: NCT00005958 - Active, not recruiting
stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; transitional cell carcinoma of the bladder; ...
- Interleukin-2, Interferon alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
ClinicalTrials.gov Identifier: NCT00053807 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00492986 - Active, not recruiting
Cancer; Renal Cell Cancer
- Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Gene Therapy in Treating Patients With Cancer
ClinicalTrials.gov Identifier: NCT00004178 - Active, not recruiting
Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
- Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003126 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- SU011248 in Treating Patients With Cytokine-Refractory Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00082849 - No longer recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma
- Allogeneic Stem Cell Transplantation in Treating Patients With Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00056095 - Recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- PS-341 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00017329 - Active, not recruiting
Stage IV Renal Cell Cancer
- Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003133 - Active, not recruiting
stage III bladder cancer; stage IV bladder cancer; metastatic transitional cell cancer of the renal pelvis and ureter; ...
- Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003342 - Active, not recruiting
stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ...
- Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients with Metastatic Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00082459 - Active, not recruiting
Renal Cell Carcinoma
- ABT-751 in Treating Patients With Locally Recurrent or Metastatic Renal Cell (Kidney) Cancer
ClinicalTrials.gov Identifier: NCT00080717 - No longer recruiting
recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
- High-Dose Interferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma
ClinicalTrials.gov Identifier: NCT00003091 - Active, not recruiting
Stage IV Melanoma; Stage IV Renal Cell Cancer; recurrent renal cell cancer; Recurrent Melanoma
- Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00465179 - Recruiting
Renal Cell Cancer; Kidney Cancer
- Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium
ClinicalTrials.gov Identifier: NCT00072150 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Bortezomib and Bevacizumab (“BB-Mib-Mab”) in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)
ClinicalTrials.gov Identifier: NCT00184015 - Recruiting
Renal Cell Cancer
- A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.
ClinicalTrials.gov Identifier: NCT00520403 - Recruiting
Renal Cell Cancer
- Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
ClinicalTrials.gov Identifier: NCT00066612 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Phase I Study of SU006668 in Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00024063 - Active, not recruiting
Lung Cancer; Pancreatic Cancer; Gastric Cancer; Renal Cell Cancer; Colorectal Cancer; Colon Cancer; Prostate Cancer; Rectal Cancer; Breast Cancer; ...
- Safety Study of an Oral VEGF Receptor Inhibitor When Combined With an m-Tor Inhibitor in Renal Cell Cancer Patients
ClinicalTrials.gov Identifier: NCT00563147 - Active, not recruiting
Renal Cell Carcinoma
- Genetic Study of Patients With von Hippel-Lindau Syndrome
ClinicalTrials.gov Identifier: NCT00003866 - Active, not recruiting
childhood kidney/urinary cancer; Renal Cell Cancer
- Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003683 - Active, not recruiting
Stage IV Renal Cell Cancer
- Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
ClinicalTrials.gov Identifier: NCT00458536 - Recruiting
Renal Cancer
- R115777 in Treating Patients With Advanced Bladder Cancer
ClinicalTrials.gov Identifier: NCT00006376 - Active, not recruiting
stage III bladder cancer; stage II bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; ...
- Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
ClinicalTrials.gov Identifier: NCT00003170 - Active, not recruiting
Pancreatic Cancer; Vulvar Cancer; Renal Cell Cancer; Endometrial Cancer; Testicular Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer; ...
- Treatment of Patients With Advanced Renal Cancer With a Radio-Labeled Antibody, Yttrium-90 Conjugated Chimeric G250.
ClinicalTrials.gov Identifier: NCT00199875 - Recruiting
Renal Cell Carcinoma; Kidney Neoplasm; Renal Cancer; Kidney Cancer
- Cellular Adoptive Immunotherapy and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00093574 - Recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00004244 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Stage IV Melanoma; Recurrent Melanoma
- 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00075660 - Completed
recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
- Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
ClinicalTrials.gov Identifier: NCT00004223 - Active, not recruiting
stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; transitional cell carcinoma of the bladder; ...
- FR901228 in Treating Patients With Advanced Cancer of the Urothelium
ClinicalTrials.gov Identifier: NCT00087295 - Active, not recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer
ClinicalTrials.gov Identifier: NCT00096525 - Completed
recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
